Energy metabolism plasticity enables stemness programs
暂无分享,去创建一个
Andre Terzic | Timothy J Nelson | Timothy J. Nelson | A. Terzic | P. Dzeja | C. Folmes | T. Nelson | Petras P Dzeja | Clifford D L Folmes | Clifford D. L. Folmes | Clifford D.L. Folmes
[1] Timothy J. Nelson,et al. Mitochondria in control of cell fate. , 2012, Circulation research.
[2] Juan Carlos Izpisua Belmonte,et al. The metabolome of induced pluripotent stem cells reveals metabolic changes occurring in somatic cell reprogramming , 2011, Cell Research.
[3] Laurent Vergnes,et al. UCP2 regulates energy metabolism and differentiation potential of human pluripotent stem cells , 2011, The EMBO journal.
[4] A. Terzic,et al. Energy metabolism in nuclear reprogramming. , 2011, Biomarkers in medicine.
[5] A. Terzic,et al. Cardiovascular Health: The Global Challenge , 2011, Clinical pharmacology and therapeutics.
[6] E. Marbán,et al. The Stuttering Progress of Cell Therapy for Heart Disease , 2011, Clinical pharmacology and therapeutics.
[7] K. Thangaraj,et al. Cellular Model of Warburg Effect Identifies Tumor Promoting Function of UCP2 in Breast Cancer and Its Suppression by Genipin , 2011, PloS one.
[8] J. Drenckhahn. Heart development: mitochondria in command of cardiomyocyte differentiation. , 2011, Developmental cell.
[9] K. L. de Mesy Bentley,et al. The permeability transition pore controls cardiac mitochondrial maturation and myocyte differentiation. , 2011, Developmental cell.
[10] Hans Lehrach,et al. Human Induced Pluripotent Stem Cells Harbor Homoplasmic and Heteroplasmic Mitochondrial DNA Mutations While Maintaining Human Embryonic Stem Cell–like Metabolic Reprogramming , 2011, Stem cells.
[11] Andre Terzic,et al. Somatic oxidative bioenergetics transitions into pluripotency-dependent glycolysis to facilitate nuclear reprogramming. , 2011, Cell metabolism.
[12] J. I. Izpisúa Belmonte,et al. Anaerobicizing into pluripotency. , 2011, Cell metabolism.
[13] A. Terzic,et al. Regenerative medicine: on the vanguard of health care. , 2011, Mayo Clinic proceedings.
[14] K. McCreath,et al. Mitochondria Determine the Differentiation Potential of Cardiac Mesoangioblasts , 2011, Stem cells.
[15] G. Schatten,et al. Energy Metabolism in Human Pluripotent Stem Cells and Their Differentiated Counterparts , 2011, PloS one.
[16] Andre Terzic,et al. Chronic Diseases: The Emerging Pandemic , 2011, Clinical and translational science.
[17] A. Nagy,et al. Human Induced Pluripotent Stem Cells: The Past, Present, and Future , 2011, Clinical pharmacology and therapeutics.
[18] Timothy J. Nelson,et al. Induced Pluripotent Stem Cells: An Emerging Theranostics Platform , 2011, Clinical pharmacology and therapeutics.
[19] S. Yamanaka,et al. The Use of Induced Pluripotent Stem Cells in Drug Development , 2011, Clinical pharmacology and therapeutics.
[20] A. Terzic,et al. Developmental Enhancement of Adenylate Kinase-AMPK Metabolic Signaling Axis Supports Stem Cell Cardiac Differentiation , 2011, PloS one.
[21] Michael D. Schneider,et al. Cardiac muscle regeneration: lessons from development. , 2011, Genes & development.
[22] J. C. Belmonte,et al. Dedifferentiation, transdifferentiation and reprogramming: three routes to regeneration , 2011, Nature Reviews Molecular Cell Biology.
[23] Aristide C. Chikando,et al. Mitofusin-2 Maintains Mitochondrial Structure and Contributes to Stress-Induced Permeability Transition in Cardiac Myocytes , 2011, Molecular and Cellular Biology.
[24] J. Adjaye,et al. Modulation of mitochondrial biogenesis and bioenergetic metabolism upon in vitro and in vivo differentiation of human ES and iPS cells. , 2010, The International journal of developmental biology.
[25] Sheng Ding,et al. Reprogramming of human primary somatic cells by OCT4 and chemical compounds. , 2010, Cell stem cell.
[26] Andre Terzic,et al. Induced pluripotent stem cells: developmental biology to regenerative medicine , 2010, Nature Reviews Cardiology.
[27] Mark Ellisman,et al. Mitochondrial Rejuvenation After Induced Pluripotency , 2010, PloS one.
[28] J. Rehman. Empowering self-renewal and differentiation: the role of mitochondria in stem cells , 2010, Journal of Molecular Medicine.
[29] A. Terzic,et al. Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction. , 2010, Journal of the American College of Cardiology.
[30] E. Marbán,et al. Boot camp for mesenchymal stem cells. , 2010, Journal of the American College of Cardiology.
[31] Alfredo Quiñones-Hinojosa,et al. Oxygen in stem cell biology: a critical component of the stem cell niche. , 2010, Cell stem cell.
[32] K. McCreath,et al. Mitochondrial Reactive Oxygen Species Mediate Cardiomyocyte Formation from Embryonic Stem Cells in High Glucose , 2010, Stem cells.
[33] H. Blau,et al. Nuclear reprogramming to a pluripotent state by three approaches , 2010, Nature.
[34] A. Terzic,et al. Regenerative medicine advancing health care 2020. , 2010, Journal of the American College of Cardiology.
[35] H. Schöler,et al. Induced pluripotent stem cells at nanoscale. , 2010, Stem cells and development.
[36] A. Terzic,et al. Cells as biologics for cardiac repair in ischaemic heart failure , 2010, Heart.
[37] D. K. Arrell,et al. Glycolytic network restructuring integral to the energetics of embryonic stem cell cardiac differentiation. , 2010, Journal of molecular and cellular cardiology.
[38] M. Stojkovic,et al. Human Induced Pluripotent Stem Cell Lines Show Stress Defense Mechanisms and Mitochondrial Regulation Similar to Those of Human Embryonic Stem Cells , 2010, Stem cells.
[39] Sunia A Trauger,et al. Metabolic oxidation regulates embryonic stem cell differentiation , 2010, Nature chemical biology.
[40] Hans Lehrach,et al. The Senescence‐Related Mitochondrial/Oxidative Stress Pathway is Repressed in Human Induced Pluripotent Stem Cells , 2010, Stem cells.
[41] P. Pasdois,et al. The role of the mitochondrial permeability transition pore in heart disease. , 2009, Biochimica et biophysica acta.
[42] Timothy J. Nelson,et al. iPS Programmed Without c-MYC Yield Proficient Cardiogenesis for Functional Heart Chimerism , 2009, Circulation research.
[43] C. Pereira,et al. Senescence impairs successful reprogramming to pluripotent stem cells. , 2009, Genes & development.
[44] T. Ichisaka,et al. Hypoxia enhances the generation of induced pluripotent stem cells. , 2009, Cell stem cell.
[45] A. Ben-Yehudah,et al. Enhancement of human embryonic stem cell pluripotency through inhibition of the mitochondrial respiratory chain. , 2009, Stem cell research.
[46] Manuel Serrano,et al. A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity , 2009, Nature.
[47] M. Blasco,et al. The Ink4/Arf locus is a barrier for iPS cell reprogramming , 2009, Nature.
[48] T. Ichisaka,et al. Suppression of induced pluripotent stem cell generation by the p53–p21 pathway , 2009, Nature.
[49] Timothy J. Nelson,et al. Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. , 2009, Circulation.
[50] R. Hammer,et al. Dependence of Mouse Embryonic Stem Cells on Threonine Catabolism , 2009, Science.
[51] Andre Terzic,et al. Stem Cell Platforms for Regenerative Medicine , 2009, Clinical and translational science.
[52] L. Cantley,et al. Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.
[53] F. Bouillaud. UCP2, not a physiologically relevant uncoupler but a glucose sparing switch impacting ROS production and glucose sensing. , 2009, Biochimica et biophysica acta.
[54] J. S. John,et al. The Relationship Between Pluripotency and Mitochondrial DNA Proliferation During Early Embryo Development and Embryonic Stem Cell Differentiation , 2009, Stem Cell Reviews and Reports.
[55] A. Terzic,et al. Induced Pluripotent Reprogramming from Promiscuous Human Stemness‐Related Factors , 2009, Clinical and translational science.
[56] M. Andreeff,et al. Mitochondrial uncoupling and the Warburg effect: molecular basis for the reprogramming of cancer cell metabolism. , 2009, Cancer research.
[57] K. Hochedlinger,et al. Epigenetic reprogramming and induced pluripotency , 2009, Development.
[58] B. Gersh,et al. Cardiac cell repair therapy: a clinical perspective. , 2009, Mayo Clinic proceedings.
[59] Breakthrough of the year. Areas to watch. , 2009, Science.
[60] K. Hochedlinger,et al. Guidelines and techniques for the generation of induced pluripotent stem cells. , 2008, Cell stem cell.
[61] A. Terzic,et al. Developmental Restructuring of the Creatine Kinase System Integrates Mitochondrial Energetics with Stem Cell Cardiogenesis , 2008, Annals of the New York Academy of Sciences.
[62] J. P. McCoy,et al. Mitochondrial Metabolism Modulates Differentiation and Teratoma Formation Capacity in Mouse Embryonic Stem Cells* , 2008, Journal of Biological Chemistry.
[63] D. K. Arrell,et al. Guided stem cell cardiopoiesis: discovery and translation. , 2008, Journal of molecular and cellular cardiology.
[64] Ryan B. Huang,et al. Effects of oxygen on mouse embryonic stem cell growth, phenotype retention, and cellular energetics. , 2008, Biotechnology and bioengineering.
[65] R. Roberts,et al. Identification of oxygen-sensitive transcriptional programs in human embryonic stem cells. , 2008, Stem cells and development.
[66] T. Mikkelsen,et al. Dissecting direct reprogramming through integrative genomic analysis , 2008, Nature.
[67] R. Jaenisch,et al. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease , 2008, Proceedings of the National Academy of Sciences.
[68] O. Lee,et al. Coordinated Changes of Mitochondrial Biogenesis and Antioxidant Enzymes During Osteogenic Differentiation of Human Mesenchymal Stem Cells , 2008, Stem cells.
[69] K. Plath,et al. Generation of human induced pluripotent stem cells from dermal fibroblasts , 2008, Proceedings of the National Academy of Sciences.
[70] C. Thompson,et al. Uncoupling protein‐2 controls proliferation by promoting fatty acid oxidation and limiting glycolysis‐derived pyruvate utilization , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[71] R. Deberardinis,et al. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. , 2008, Cell metabolism.
[72] Shulan Tian,et al. Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells , 2007, Science.
[73] S. Egginton,et al. Mitochondrial DNA replication during differentiation of murine embryonic stem cells , 2007, Journal of Cell Science.
[74] B. Bavister,et al. Mitochondria in stem cells. , 2007, Mitochondrion.
[75] Marius Wernig,et al. Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells , 2007, Nature Biotechnology.
[76] T. Ichisaka,et al. Generation of germline-competent induced pluripotent stem cells , 2007, Nature.
[77] R. Jaenisch,et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state , 2007, Nature.
[78] Sabine S. Lange,et al. Stimulation of ES-cell-derived cardiomyogenesis and neonatal cardiac cell proliferation by reactive oxygen species and NADPH oxidase , 2007, Journal of Cell Science.
[79] Andre Terzic,et al. Mitochondrial oxidative metabolism is required for the cardiac differentiation of stem cells , 2007, Nature Clinical Practice Cardiovascular Medicine.
[80] D. K. Arrell,et al. Stem cells transform into a cardiac phenotype with remodeling of the nuclear transport machinery , 2007, Nature Clinical Practice Cardiovascular Medicine.
[81] Sujin Kwon,et al. Dynamic changes in mitochondrial biogenesis and antioxidant enzymes during the spontaneous differentiation of human embryonic stem cells. , 2006, Biochemical and biophysical research communications.
[82] H. Baharvand,et al. Ultrastructural comparison of developing mouse embryonic stem cell‐ and in vivo‐derived cardiomyocytes , 2006, Cell biology international.
[83] S. Yamanaka,et al. Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.
[84] Eyal Gottlieb,et al. TIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis , 2006, Cell.
[85] B. Bavister,et al. Differentiation‐related changes in mitochondrial properties as indicators of stem cell competence , 2006, Journal of cellular physiology.
[86] A. Terzic,et al. Derivation of a cardiopoietic population from human mesenchymal stem cells yields cardiac progeny , 2006, Nature Clinical Practice Cardiovascular Medicine.
[87] M. Pucéat. Role of Rac-GTPase and reactive oxygen species in cardiac differentiation of stem cells. , 2005, Antioxidants & redox signaling.
[88] G. Schatten,et al. The expression of mitochondrial DNA transcription factors during early cardiomyocyte in vitro differentiation from human embryonic stem cells. , 2005, Cloning and stem cells.
[89] A. Tabilio,et al. Characterization of Mitochondrial and Extra-mitochondrial Oxygen Consuming Reactions in Human Hematopoietic Stem Cells , 2005, Journal of Biological Chemistry.
[90] R. Roberts,et al. Low O2 tensions and the prevention of differentiation of hES cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[91] B. Fleischmann,et al. Activity of complex III of the mitochondrial electron transport chain is essential for early heart muscle cell differentiation , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[92] M. Pucéat,et al. A dual role of the GTPase Rac in cardiac differentiation of stem cells. , 2003, Molecular biology of the cell.
[93] A. Terzic,et al. Structural Adaptation of the Nuclear Pore Complex in Stem Cell–Derived Cardiomyocytes , 2003, Circulation research.
[94] H. Nau,et al. Anticonvulsant valproic acid inhibits cardiomyocyte differentiation of embryonic stem cells by increasing intracellular levels of reactive oxygen species. , 2003, Birth defects research. Part A, Clinical and molecular teratology.
[95] H. Baharvand,et al. The ultrastructure of mouse embryonic stem cells. , 2003, Reproductive biomedicine online.
[96] E. Couplan,et al. No Evidence for a Basal, Retinoic, or Superoxide-induced Uncoupling Activity of the Uncoupling Protein 2 Present in Spleen or Lung Mitochondria* , 2002, The Journal of Biological Chemistry.
[97] S. Bonhoeffer,et al. Cooperation and Competition in the Evolution of ATP-Producing Pathways , 2001, Science.
[98] B. Miroux,et al. Uncoupling Protein 2, in Vivo Distribution, Induction upon Oxidative Stress, and Evidence for Translational Regulation* , 2001, The Journal of Biological Chemistry.
[99] J. Hescheler,et al. Effects of electrical fields on cardiomyocyte differentiation of embryonic stem cells , 1999, Journal of cellular biochemistry.